Market Overview

A Look At Benzinga Pro's Most-Searched Tickers For June 17

Share:

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. ContraVir Pharmaceuticals (NASDAQ: CTRV) shares were up 40% to $12.37. The company reported positive results from human liver experiments with its NASH drug candidate.
  2. Array BioPharma Inc (NASDAQ: ARRY) shares were up 55% to $46 after the company announced it would be acquired by Pfizer for $48 per share in cash.
  3. ArQule, Inc (NASDAQ: ARQL) shares were up 15% to $9.45. The company announced preliminary results from its Phase 1/2 study of miransertib in patients with PIKCA-3CA-related Overgrowth Spectrum and Proteus syndrome in an Oral Presentation at the European Society of Human Genetics Conference
  4. Dare Biosciences, Inc (NASDAQ: DARE) shares were 11% to 99 cents after the company reported results from its thermography study of sildenafil showed "the utility of thermography technology to detect statistically meaningful differences in genital temperature changes."
  5. VBI Vaccines Inc (NASDAQ: VBIV) shares were down 61% after the company reported results from its Phase 3 study of Sci-B-Vac. The trial met both co-primary endpoints but did not meet its secondary objective on non-inferiority.
  6. Facebook Inc (NASDAQ: FB) shares were up 2.9% to $186.50. The stock has experienced continued momentum since it signed up several companies to back its new cryptocurrency.
  7. Riot Blockchain (NASDAQ: RIOT) shares were up 4.7% to $2.86.
  8. Beyond Meat (NASDAQ: BYND) shares were up 12% to $169.79. The company has experienced continued volatility since its IPO.
  9. Energy Focus Inc (NASDAQ: EFOI) shares were up 15% at 50 cents.
  10. ReWalk Robotics (NASDAQ: RWLK) shares were up 2.7% to $5.35 after H.C. Wainwright upgraded the stock from Neutral to Buy and raised the price target from $4 to $9.

Posted-In: Cryptocurrency News Intraday Update Markets Trading Ideas

 

Related Articles (ARQL + ARRY)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Option Trader Selling The Yeti Bounce

Baird: Broadcom Lowers Full-Year Revenue Outlook On High Channel Inventory